CXCL12 can be released by injured hepatocytes, biliary epithelial cells, sinusoidal endothelial cells, tumor-associated leukocytes, and HCC cells themselves and have proinflammatory, profibrotic, and proangiogenic functions [15]. This evidence concerns the gene CXCL12 and neoplasm.